Colucci; John
Patent Applications and Registrations
Patent applications and USPTO patent grants for Colucci; John.The latest application filed is for "novel prodrug salts".
Company Profile
2.27.29
- Colucci; John - Kirkland CA
- Colucci; John - Westmount CA
- Colucci; John - Montreal CA
Patent Activity
| Patent | Date |
|---|---|
| Novel Prodrug Salts App 20220143048 - Pelletier; Marc F. ; et al. | 2022-05-12 |
| Prodrug salts Grant 11,071,744 - Pelletier , et al. July 27, 2 | 2021-07-27 |
| Novel Prodrug Salts App 20200297740 - PELLETIER; Marc F. ; et al. | 2020-09-24 |
| Prodrug salts Grant 10,258,636 - Pelletier , et al. | 2019-04-16 |
| Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahy- dro-1,8-naphthyridin-3-yl)acrylamide Grant 10,035,813 - Partridge , et al. July 31, 2 | 2018-07-31 |
| Novel Prodrug Salts App 20180169118 - PELLETIER; Marc F. ; et al. | 2018-06-21 |
| Prodrug salts Grant 9,827,253 - Pelletier , et al. November 28, 2 | 2017-11-28 |
| Novel Prodrug Salts App 20160264604 - PELLETIER; Marc F. ; et al. | 2016-09-15 |
| Fused aromatic PTP-1B inhibitors Grant 9,334,295 - Colucci , et al. May 10, 2 | 2016-05-10 |
| Indole derivatives as CRTH2 receptor antagonists Grant 9,023,864 - Berthelette , et al. May 5, 2 | 2015-05-05 |
| Prodrug Derivatives Of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahy- Dro-1,8-naphthyridin-3-yl)acrylamide App 20150065415 - Partridge; John J. ; et al. | 2015-03-05 |
| Fused Aromatic Ptp-1b Inhibitors App 20150045325 - Colucci; John ; et al. | 2015-02-12 |
| Fused aromatic PTP-1B inhibitors Grant 8,927,526 - Colucci , et al. January 6, 2 | 2015-01-06 |
| Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin- -3-yl)acrylamide Grant 8,901,105 - Partridge , et al. December 2, 2 | 2014-12-02 |
| Prodrug Derivatives Of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahy- Dro-1,8-naphthyridin-3-yl)acrylamide App 20140051666 - Partridge; John J. ; et al. | 2014-02-20 |
| Indole derivatives as CRTH2 receptor antagonists Grant 8,637,671 - Colucci , et al. January 28, 2 | 2014-01-28 |
| Fused Aromatic Ptp-1b Inhibitors App 20130281365 - COLUCCI; John ; et al. | 2013-10-24 |
| Fused aromatic PTP-1B inhibitors Grant 8,481,742 - Colucci , et al. July 9, 2 | 2013-07-09 |
| Indole Derivatives as CRTH2 Receptor Antagonists App 20130150398 - Berthelette; Carl ; et al. | 2013-06-13 |
| Indole derivatives as CRTH2 receptor antagonists Grant 8,394,819 - Berthelette , et al. March 12, 2 | 2013-03-12 |
| Fused Aromatic Ptp-ib Inhibitors App 20120178679 - COLUCCI; John ; et al. | 2012-07-12 |
| Fused aromatic PTP-1B inhibitors Grant 8,168,815 - Colucci , et al. May 1, 2 | 2012-05-01 |
| Indole and indoline cyclopropyl amide derivatives as EP4 receptor antagonists Grant 8,158,671 - Boyd , et al. April 17, 2 | 2012-04-17 |
| EP4 Receptor Agonist, Compositions and Methods Thereof App 20110237511 - Billot; Xavier ; et al. | 2011-09-29 |
| Quinoline derivatives as EP4 antagonists Grant 8,013,159 - Belley , et al. September 6, 2 | 2011-09-06 |
| EP.sub.4 receptor agonist, compositions and methods thereof Grant RE42,562 - Billot , et al. July 19, 2 | 2011-07-19 |
| Indole Derivatives As Crth2 Receptor Antagonists App 20110172263 - Colucci; John ; et al. | 2011-07-14 |
| Indole amide derivatives as EP4 receptor antagonists Grant 7,968,578 - Boyd , et al. June 28, 2 | 2011-06-28 |
| Indole Derivatives As Crth2 Receptor Antagonists App 20100234415 - Berthelette; Carl ; et al. | 2010-09-16 |
| Indoline amide derivatives as EP4 receptor ligands Grant 7,705,035 - Boyd , et al. April 27, 2 | 2010-04-27 |
| Fused Aromatic Ptp-1b Inhibitors App 20100022477 - Colucci; John ; et al. | 2010-01-28 |
| Indole And Indoline Cyclopropyl Amide Derivatives As Ep4 Receptor Antagonists App 20090318518 - Boyd; Michael ; et al. | 2009-12-24 |
| EP4 Receptor Agonist, Compositions and Methods Thereof App 20090270395 - Colucci; John ; et al. | 2009-10-29 |
| Indole Amide Derivatives as EP4 Receptor Antagonists App 20090253756 - Boyd; Michael ; et al. | 2009-10-08 |
| Indole Amide Derivatives as Ep4 Receptot Ligands App 20090105321 - Boyd; Michael ; et al. | 2009-04-23 |
| EP4 Receptor Agonist, Compositions and Methods Thereof App 20090105234 - Colucci; John ; et al. | 2009-04-23 |
| Quinoline derivatives as ep4 antagonists App 20090099226 - Belley; Michel ; et al. | 2009-04-16 |
| EP.sub.4 receptor agonist, compositions and methods thereof Grant 7,238,710 - Billot , et al. July 3, 2 | 2007-07-03 |
| EP4 receptor agonist, compositions and methods thereof App 20060270721 - Han; Yongxin ; et al. | 2006-11-30 |
| Oxazolidin-2-one and thiazolidin-2-one derivatives for use as EP.sub.4 receptor agonists in the treatment of glaucoma Grant 7,109,223 - Han , et al. September 19, 2 | 2006-09-19 |
| Ep4 receptor agonists App 20060167081 - Billot; Xavier ; et al. | 2006-07-27 |
| Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma App 20060154899 - Han; Yongxin ; et al. | 2006-07-13 |
| EP.sub.4 receptor agonist, compositions and methods thereof Grant 7,053,085 - Billot , et al. May 30, 2 | 2006-05-30 |
| Irreversible caspase-3 inhibitors as active site probes App 20060069038 - Colucci; John ; et al. | 2006-03-30 |
| EP4 receptor agonist, compositions and methods thereof App 20050227969 - Billot, Xavier ; et al. | 2005-10-13 |
| EP4 receptor agonist, compositions and methods thereof App 20040198701 - Billot, Xavier ; et al. | 2004-10-07 |
| Pyrazinones, compositions containing such compounds and methods of use Grant 6,699,856 - Han , et al. March 2, 2 | 2004-03-02 |
| Pyrazinones, compositions containing such compounds and methods of use App 20030236402 - Han, Yongxin ; et al. | 2003-12-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 